These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 409479)

  • 1. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
    Cadman EC; Capizzi RL; Bertino JR
    Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
    Aisenberg AC
    Am J Med; 1983 Sep; 75(3):449-54. PubMed ID: 6688502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
    J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-therapeutic acute leukemia.
    Auclerc G; Jacquillat C; Auclerc MF; Weil M; Bernard J
    Cancer; 1979 Dec; 44(6):2017-25. PubMed ID: 389405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of new cancers in patients with Hodgkin's disease.
    Arseneau JC; Canellos GP; Johnson R; DeVita VT
    Cancer; 1977 Oct; 40(4 Suppl):1912-6. PubMed ID: 907993
    [No Abstract]   [Full Text] [Related]  

  • 10. Hodgkin's disease terminating in acute leukaemia: report of seven cases.
    Wolf MM; Cooper IA; Ding JC
    Aust N Z J Med; 1979 Aug; 9(4):398-402. PubMed ID: 292379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
    Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
    J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of acute nonlymphocytic leukemia in a prospective randomized study of treatment for Hodgkin's disease.
    Gomez GA; Friedman M; Reese P
    Am J Clin Oncol; 1983 Jun; 6(3):319-23. PubMed ID: 6342359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
    Valagussa P; Santoro A; Kenda R; Fossati Bellani F; Franchi F; Banfi A; Rilke F; Bonadonna G
    Br Med J; 1980 Jan; 280(6209):216-9. PubMed ID: 6775732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary leukemia following treatment of Hodgkin's disease: ultrastructural and cytogenetic data in two cases with a review of the literature.
    Yahalom J; Voss R; Leizerowitz R; Fuks Z; Polliack A
    Am J Clin Pathol; 1983 Aug; 80(2):231-6. PubMed ID: 6349327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary leukemia following treatment for Hodgkin's disease.
    Salvagno L; Simonato L; Sorarù M; Bianco A; Chiarion-Sileni V; Aversa SM; Camporese R; Garofolin P; Fiorentino M
    Tumori; 1993 Apr; 79(2):103-7. PubMed ID: 8346559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
    J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease.
    Mendenhall NP; Shuster JJ; Million RR
    Radiother Oncol; 1989 Mar; 14(3):219-29. PubMed ID: 2710953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second malignant lesions after therapy for Hodgkin's disease.
    Schomberg PJ; Evans RG; Banks PM; White WL; O'Connell MJ; Earle JD
    Mayo Clin Proc; 1984 Jul; 59(7):493-7. PubMed ID: 6588280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin's lymphoma and acute myeloblastic leukemia: a report of 12 cases and review of the literature.
    Zarrabi MH; Rosner F; Bennett JM
    Cancer; 1979 Sep; 44(3):1070-80. PubMed ID: 383266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.